Most of us are still recovering from the chaos COVID brought to travel just a few years ago. With travel anxiety on the rise and a new virus spreading, it’s crucial to understand how mpox could impact your plans.
Mpox, formerly known as monkeypox, is a viral illness spread through physical contact—whether that’s with someone who is infected, certain animals, or contaminated materials like clothing and bedding. Symptoms typically include fever, headache, muscle aches, back pain, and a distinctive skin rash with lesions that can linger for two to four weeks.
On August 14, the UN World Health Organization (WHO) declared the recent increase in Monkeypox virus (MPXV) cases as a “public health emergency of international concern,” its highest alert level. Just one day later, Sweden reported the first confirmed case of the new mpox strain outside Africa. Most cases have been concentrated in Africa, involving the more severe Clade 1 strain, which has resulted in higher rates of severe illness and fatalities.
However, as of August 23, Clade 1 mpox has not yet been detected in the US. WHO officials have been clear: this is not the new COVID. There’s currently no mandatory vaccination requirement for travellers against mpox. However, the CDC has issued a Level 2 Travel Health Notice for those visiting the Democratic Republic of Congo and neighbouring countries. Travelers to these regions are encouraged to get vaccinated, with two doses providing the best protection.
If you’re immunocompromised, consider travel insurance that includes comprehensive health coverage. And no matter where you’re headed, staying informed is key—rely on trusted sources like the WHO and CDC for the latest updates. Stay safe and travel smart!
Leave a Reply